| Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. | ovarian, |
| [Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors]. | ovarian, |
| [Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma]. | gastric, |
| [Relationship between c-erbB2 oncoprotein expression and biologic behavior of cervical squamous cell cancer]. | cervical, |
| In vivo overexpression of c-erbB-2 oncoprotein in xenografts of mice implanted with human colon cancer lines. | colorectal, |
| Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1. | ovarian, |
| The prognostic value of HER-2/neu oncogene in cervical cancer. | cervical, |
| Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer. | ovarian, |
| Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. | breast, |
| Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung. | lung, |
| Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. | breast, |
| Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene. | breast, |
| Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions. | oral |
| Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices. | breast, |
| Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu. | breast, |
| A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. | sarcoma, |
| ERBB2 oncogene in human breast cancer and its clinical significance. | breast, |
| Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients. | lung, |
| The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. | breast, |
| Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer. | breast, |